Evaluation of Efficacy and Safety of Ayush-HR in the management of Pre-Hypertension- A Double Blind Randomized control clinical study

CCRAS0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients who have history of Cardiac Arrhythmia, Acute Coronary Syndrome, Myocardial Infarction, congestive cardiac failure ,Stroke or Severe Arrhythmia in the last 6 months.
•2.Essential Hypertension / Secondary hypertension.
•3.Patients with concurrent Hepatic Dysfunction (defined as AST and/or ALT > 2 times of the upper normal limit) or Renal Dysfunction (defined as S. creatinine > 1.2 mg/dl),uncontrolled Pulmonary Dysfunction (asthmatic and COPD patients) or major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Neurological disorders, Endocrinal disorders, etc.) or Known cases of malignancy
•4.Uncontrolled Diabetes Mellitus(HbA1C >8)
•5.Women who are planning for conception / pregnant or lactating.
•6.H/o hypersensitivity to any of the trial drugs or their ingredients.
•7.Patient taking participation in any other clinical trial.
•8.Any other condition which the P.I. thinks may jeopardize the study.

发起方

CCRAS